Summit Financial Wealth Advisors’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$295K Hold
103,288
– – 0.04% 176
2026
Q2
$314K Hold
103,288
– – 0.04% 173
2026
Q1
$318K Hold
103,288
– – 0.05% 148
2025
Q4
$373K Buy
103,288
+7,000
+7% +$30.5K 0.05% 132
2025
Q3
$373K Sell
96,288
-26,700
-22% -$103K 0.06% 121
2025
Q2
$476K Buy
122,988
+5,000
+4% +$27.1K 0.09% 97
2025
Q1
$590K Buy
117,988
+18,500
+19% +$117K 0.12% 84
2024
Q4
$641K Buy
99,488
+53,570
+117% +$409K 0.13% 82
2024
Q3
$282K Buy
45,918
+18,113
+65% +$123K 0.05% 124
2024
Q2
$185K Buy
+27,805
New +$205K 0.04% 140

Other funds holding ALT

Summit Financial Wealth Advisors's ALT Position: Q3 2026 in Review

Summit Financial Wealth Advisors held its Altimmune (ALT) position steady in Q3 2026 at 103,288 shares worth $295K. The position accounts for 0.04% of the portfolio, ranked #176.

Summit Financial Wealth Advisors first reported a position in ALT in Q2 2024 and has held it in 10 quarters since. The position peaked at $641K in Q4 2024. 191 funds tracked by Wall St. Rank hold ALT as of Q3 2026.

  • Summit Financial Wealth Advisors held 103,288 shares of Altimmune worth $295K as of Q3 2026.
  • Summit Financial Wealth Advisors left its Altimmune share count unchanged in Q3 2026.
  • Altimmune made up 0.04% of Summit Financial Wealth Advisors's portfolio in Q3 2026, its #176 holding.
  • Summit Financial Wealth Advisors first reported a position in Altimmune in Q2 2024 and has held it in 10 quarters since.
  • Summit Financial Wealth Advisors's Altimmune position peaked at $641K in Q4 2024.
  • 191 funds tracked by Wall St. Rank held Altimmune as of Q3 2026.

Based on Summit Financial Wealth Advisors's 13F filing for Q3 2026, filed 15 Oct 2026.